251 - 275 of 5832 Results
Title
Year
-
OPENTitle: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2Journal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 300Issue #: 7Start Page: 107469End Page: 107469Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469Citation Count: 0
-
OPENTitle: Parkinson's disease: Still waiting for a cureJournal Name: Clinical and Translational SciencePublisher: WileyVol: 17Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/cts.13898Citation Count: 1
-
OPENTitle: Profiling people with Parkinson's disease at risk of cognitive decline: Insights from PPMI and ICICLE‐PD dataJournal Name: Alzheimer's & Dementia: Diagnosis, Assessment & Disease MonitoringPublisher: WileyVol: 16Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1002/dad2.12625Citation Count: 0
-
OPENTitle: Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of α-synuclein inclusionsJournal Name: NeuronPublisher: Elsevier BVVol: 112Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuron.2024.06.002Best OA location URL: https://doi.org/10.1016/j.neuron.2024.06.002Citation Count: 0
-
OPENTitle: Associations of cholinergic system integrity with cognitive decline in GBA1 and LRRK2 mutation carriersJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00743-wCitation Count: 1
-
OPENTitle: Increased mean diffusivity of the caudal motor SNc identifies patients with REM sleep behaviour disorder and Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00731-0Citation Count: 1
-
OPENTitle: Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65010-7Citation Count: 1
- Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's Disease2024OPENTitle: Investigating the Protective Role of the Mitochondrial 2158 T > C Variant in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 9Start Page: 1645End Page: 1647Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29892Citation Count: 0
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup2024OPENTitle: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 8Start Page: 5143End Page: 5169Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.13859Best OA location URL: https://doi.org/10.1002/alz.13859Citation Count: 261
-
OPENTitle: Selective Activation of the Spinal Cord with Epidural Electrical StimulationJournal Name: Brain SciencesPublisher: MDPI AGVol: 14Issue #: 7Start Page: 650End Page: 650Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci14070650Citation Count: 1
-
OPENTitle: Assessment tools for cognitive performance in Parkinson’s disease and its genetic contributorsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2024.1413187Citation Count: 3
-
OPENTitle: Divergent landscapes of A-to-I editing in postmortem and living human brainJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49268-zBest OA location URL: https://doi.org/10.1038/s41467-024-49268-zCitation Count: 0
-
OPENTitle: The annotation of GBA1 has been concealed by its protein-coding pseudogene GBAP1Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 26Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.adk1296Citation Count: 6
-
OPENTitle: Control of mitophagy initiation and progression by the TBK1 adaptors NAP1 and SINTBADJournal Name: Nature Structural & Molecular BiologyPublisher: Springer Science and Business Media LLCVol: 31Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41594-024-01338-yBest OA location URL: https://www.nature.com/articles/s41594-024-01338-y.pdfCitation Count: 3
-
OPENTitle: Prediction of motor and non-motor Parkinson’s disease symptoms using serum lipidomics and machine learning: a 2-year studyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00741-yCitation Count: 0
-
OPENTitle: Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman PrimatesJournal Name: eneuroPublisher: Society for NeuroscienceVol: 11Issue #: 7Start Page: ENEURO.0001End Page: 24.2024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-sa, cc-by-nc-saDOI - Digital Object Identifier: 10.1523/eneuro.0001-24.2024Citation Count: 0
- The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s disease2024OPENTitle: The combined effect of lifestyle factors and polygenic scores on age at onset in Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-024-65640-xCitation Count: 0
-
OPENTitle: An interpretable machine learning‐based cerebrospinal fluid proteomics clock for predicting age reveals novel insights into brain agingJournal Name: Aging CellPublisher: WileyVol: 23Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/acel.14230Citation Count: 0
-
OPENTitle: Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.14145Citation Count: 0
-
OPENTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Citation Count: 0
-
OPENTitle: Open-source platform for kinematic analysis of mouse forelimb movementJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 5Issue #: 3Start Page: 103140End Page: 103140Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.xpro.2024.103140Citation Count: 0
-
OPENTitle: Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 9Start Page: 2631End Page: 2640Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-03101-8Citation Count: 6
-
OPENTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Best OA location URL: https://www.nature.com/articles/s41467-024-49256-3.pdfCitation Count: 0
-
OPENTitle: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onsetJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-48961-3Best OA location URL: https://www.nature.com/articles/s41467-024-48961-3.pdfCitation Count: 5
-
OPENTitle: Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson diseaseJournal Name: Nature Mental HealthPublisher: Springer Science and Business Media LLCVol: 2Issue #: 8Start Page: 916End Page: 923Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s44220-024-00256-8Citation Count: 0